BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 8 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,017,520 | -37.6% | 11,500 | -38.8% | 0.00% | 0.0% |
| Q2 2023 | $1,629,584 | -39.9% | 18,800 | -32.6% | 0.00% | -66.7% |
| Q1 2023 | $2,712,996 | -27.6% | 27,900 | -22.9% | 0.00% | -50.0% |
| Q4 2022 | $3,746,338 | +253.4% | 36,200 | +189.6% | 0.01% | +500.0% |
| Q3 2022 | $1,060,000 | -47.2% | 12,500 | -44.9% | 0.00% | -50.0% |
| Q4 2021 | $2,006,000 | -59.1% | 22,700 | -61.4% | 0.00% | -66.7% |
| Q2 2021 | $4,906,000 | +12.6% | 58,800 | +1.9% | 0.01% | 0.0% |
| Q1 2021 | $4,357,000 | -22.6% | 57,700 | -10.1% | 0.01% | -14.3% |
| Q4 2020 | $5,630,000 | +345.8% | 64,200 | +286.7% | 0.01% | +250.0% |
| Q3 2020 | $1,263,000 | – | 16,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maven Securities LTD | 38,500 | $2,907,000 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75 | $566,000 | 0.02% |
| GROUP ONE TRADING, L.P. | 150,100 | $11,334,000 | 0.02% |
| SIMPLEX TRADING, LLC | 752 | $5,678,000 | 0.01% |
| IMC-Chicago, LLC | 57,700 | $4,357,000 | 0.01% |
| Worth Venture Partners, LLC | 4,500 | $13,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 43,400 | $3,277,000 | 0.00% |